Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.

Hdl Handle:
http://hdl.handle.net/10147/228074
Title:
Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.
Authors:
Smyth, L G; Mulvin, D W
Affiliation:
Department of Urology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland. elizabethsmyth@rcsi.ie
Citation:
Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland. 2012, 181 (1):33-5 Ir J Med Sci
Journal:
Irish journal of medical science
Issue Date:
Mar-2012
URI:
http://hdl.handle.net/10147/228074
DOI:
10.1007/s11845-011-0774-5
PubMed ID:
22057660
Abstract:
Prostate cancer is the most common solid cancer affecting men in Ireland. Transrectal ultrasound (TRUS) biopsies of the prostate are routinely performed to diagnose prostate cancer. They are, in general, a safe procedure but are associated with a significant risk of infective complications ranging from fever, urinary tract infection to severe urosepsis. At present, there are no recommended national guidelines on the use of antibiotic prophylaxis to minimise the risk of infective complications post-TRUS biopsy.
Item Type:
Article
Language:
en
MeSH:
Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Humans; Ireland; Male; Practice Guidelines as Topic; Prostate; Prostatic Neoplasms; Questionnaires; Ultrasonography, Interventional
ISSN:
1863-4362

Full metadata record

DC FieldValue Language
dc.contributor.authorSmyth, L Gen_GB
dc.contributor.authorMulvin, D Wen_GB
dc.date.accessioned2012-06-08T14:56:31Z-
dc.date.available2012-06-08T14:56:31Z-
dc.date.issued2012-03-
dc.identifier.citationAntibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland. 2012, 181 (1):33-5 Ir J Med Scien_GB
dc.identifier.issn1863-4362-
dc.identifier.pmid22057660-
dc.identifier.doi10.1007/s11845-011-0774-5-
dc.identifier.urihttp://hdl.handle.net/10147/228074-
dc.description.abstractProstate cancer is the most common solid cancer affecting men in Ireland. Transrectal ultrasound (TRUS) biopsies of the prostate are routinely performed to diagnose prostate cancer. They are, in general, a safe procedure but are associated with a significant risk of infective complications ranging from fever, urinary tract infection to severe urosepsis. At present, there are no recommended national guidelines on the use of antibiotic prophylaxis to minimise the risk of infective complications post-TRUS biopsy.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Irish journal of medical scienceen_GB
dc.subject.meshAnti-Bacterial Agents-
dc.subject.meshAntibiotic Prophylaxis-
dc.subject.meshBacterial Infections-
dc.subject.meshBiopsy-
dc.subject.meshHumans-
dc.subject.meshIreland-
dc.subject.meshMale-
dc.subject.meshPractice Guidelines as Topic-
dc.subject.meshProstate-
dc.subject.meshProstatic Neoplasms-
dc.subject.meshQuestionnaires-
dc.subject.meshUltrasonography, Interventional-
dc.titleAntibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Urology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland. elizabethsmyth@rcsi.ieen_GB
dc.identifier.journalIrish journal of medical scienceen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.